by Paul J. McAndrews | May 11, 2026 | Uncategorized
The Wall Street Journal recently reported on a pharmaceutical company named Veradermics, and their stock has been soaring due to the positive results in FDA Phase 2/3 trials for androgenetic alopecia. A new oral medication, VDPHL01, to treat androgenetic alopecia is...
by Paul J. McAndrews | May 5, 2026 | Medications
What Is Spironolactone? Spironolactone is an oral prescription medication that was FDA-approved in 1960 for conditions such as heart failure, hypertension (high blood pressure), and edema (fluid retention). It is a potassium sparing diuretic. It works by blocking the...
by Paul J. McAndrews | Apr 26, 2026 | Uncategorized
The short answer is NO. There is currently a lot of contradictory information circulating on the internet associated with an increased risk of depression with finasteride. This is based on faulty case reports and studies (poorly designed studies with selection bias...
by Paul J. McAndrews | Apr 10, 2026 | Uncategorized
What is a Peptide? Peptides are short chains of amino acids, and are generally defined as having small chains of 2 to 50 amino acids with a simple structure. The FDA Classification has peptides regulated as a small-molecule drug, and they are often chemically...
by Paul J. McAndrews | Mar 30, 2026 | Uncategorized
THO7 topical spray is an experimental hair loss treatment presently in clinical studies. It has been in the media stating it’s the latest and greatest treatment for hair loss and is better than finasteride and minoxidil. This is categorically unfounded and...
